Target intelligence / Profile preview

Methylglyoxal (MG) (MG)

Target
MG
Molecular classification
Metabolite, Reactive dicarbonyl, Other
01

Overview

Methylglyoxal (MG) is a highly reactive α-dicarbonyl metabolite primarily produced as a byproduct of the glycolytic pathway through the non-enzymatic degradation of triose phosphates (Source: PubMed, PMID: 24563827). It serves as the principal precursor for the formation of advanced glycation end-products (AGEs), which are irreversible modifications of proteins and DNA that accumulate during aging and diabetes (Source: NIH, StatPearls). Elevated levels of MG lead to "dicarbonyl stress," causing structural and functional damage to long-lived proteins such as collagen and basement membrane components, thereby contributing to diabetic nephropathy, retinopathy, and cardiovascular complications (Source: Nature Reviews Drug Discovery). Pharmacological targeting of MG involves the use of small-molecule scavengers like aminoguanidine and pyridoxamine, which neutralize the reactive carbonyl group before it can modify proteins (Source: PubChem). Additionally, therapeutic strategies include the activation of the glyoxalase system, particularly Glyoxalase 1 (GLO1), to accelerate the enzymatic detoxification of MG into D-lactate (Source: UniProt). Metformin, a first-line treatment for type 2 diabetes, has also been shown to possess MG-scavenging properties, contributing to its vascular protective effects (Source: PubMed, PMID: 27535878). Despite the potential of MG-targeting agents, clinical development has been hindered by safety concerns, including off-target reactivity with essential vitamins like pyridoxal phosphate and lack of long-term efficacy in human trials (Source: Wikipedia, Advanced Glycation End-product).

Other names
2-oxopropanalPyruvaldehydeMethyl glyoxalMethylglyoxal / advanced glycation end-product formationAdvanced glycation end-product formation
02

Mechanism of action

Direct chemical scavenging of reactive dicarbonyl species, inhibition of non-enzymatic glycation, breaking of established advanced glycation end-product (AGE) cross-links, and pharmacological induction of the glyoxalase 1 (GLO1) detoxification enzyme.

03

Biological functions

Protein modificationOxidative stressOther
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseDiabetes mellitusOther
05

Safety considerations

Vitamin B6 (pyridoxal phosphate) depletionRisk of systemic vasculitisHepatotoxicityInterference with physiological dicarbonyl signaling
06

Interacting drugs

Aminoguanidine

6 more in the full profile.

07

Biomarkers

Methylglyoxal-derived hydroimidazolone (MG-H1)N-epsilon-(carboxyethyl)lysine (CEL)Arg-pyrimidinePlasma methylglyoxal levelsGlyoxalase 1 (GLO1) activity

Beyond the preview

Go deeper on Methylglyoxal (MG) (MG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methylglyoxal (MG) (MG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call